Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions
Status:
Completed
Trial end date:
2016-10-28
Target enrollment:
Participant gender:
Summary
This is a clinical trial to evaluate the intravenous administration of indocyanine green
(ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine
if intravenous ICG allows us to identify intra-thoracic lesions.